Today: 10 June 2026
Fabrinet stock slides after T. Rowe Price filing as tech shares dip
8 January 2026
1 min read

Fabrinet stock slides after T. Rowe Price filing as tech shares dip

New York, Jan 8, 2026, 15:42 EST — Regular session

Fabrinet shares fell 6.5% to $439.75 in afternoon trade on Thursday, down $30.75 from the prior close, after touching a session low of $431.20.

The drop tracked declines across electronics contract manufacturers and AI-linked hardware, with Celestica down 6.3%, Sanmina off 3.7% and Nvidia lower by about 2%.

Separately, T. Rowe Price Associates disclosed in a Schedule 13G filing that it held 4.04 million Fabrinet shares, or 11.3% of the company, as of Dec. 31. Schedule 13G is a short-form report used by investors who cross the 5% ownership threshold without a control intent.

In the broader market, the S&P 500 technology index was down 1.7% as investors turned more selective on stocks tied to artificial-intelligence spending. “It’s become a ‘show me’ sector,” said Art Hogan, chief market strategist at B. Riley Wealth. Reuters

Fabrinet, which makes optical communication components and other precision products for equipment makers, last reported quarterly revenue of $978.1 million and adjusted earnings of $2.92 a share. The company forecast December-quarter revenue of $1.05 billion to $1.10 billion and adjusted earnings of $3.15 to $3.30 per share.

The selloff leaves investors looking for the next signpost on demand for optical gear and related data-center builds, where order timing can swing quickly and move sentiment with it.

Fabrinet has warned that supply constraints, swings in customer demand and reliance on a small group of customers and suppliers could hit results if orders slow or parts are hard to source.

Stock Market Today

  • Apotex Shares Surge After C$1.3 Billion IPO Launch
    June 10, 2026, 11:34 AM EDT. Apotex shares jumped 17% above the offering price as trading commenced, following a C$1.3 billion initial public offering (IPO), marking the largest in Canada in recent years. The stock later tempered gains slightly. This strong debut highlights significant investor interest in Apotex, a key player in the pharmaceutical sector.

Latest articles

Dow Drops After CPI Surprise, Iran Concerns Keep Fed Outlook Uncertain

Dow Drops After CPI Surprise, Iran Concerns Keep Fed Outlook Uncertain

10 June 2026
Dow drops 0.55% to 50,592 after May CPI jumps 4.2% year-on-year, matching forecasts but fueled by a 7% surge in gasoline prices and rising energy costs, as renewed U.S.-Iran tensions and sharp losses in AI and industrial stocks add to investor caution, with Super Micro Computer plunging 14.2% on $7 billion equity plans and XPO, J.B. Hunt, Old Dominion falling up to 6.2% after Amazon expands freight service.
S&P 500 Swings After Hot CPI, AI Names Under Pressure

S&P 500 Swings After Hot CPI, AI Names Under Pressure

10 June 2026
May inflation jumped 4.2%—the fastest pace since April 2023—matching forecasts but keeping the Fed on hold, as energy prices fueled the rise; S&P 500 and Nasdaq steadied after early losses, but AI-linked stocks slid, with Super Micro Computer tumbling on a $7 billion share sale plan that risks diluting investors.
Leonardo DRS stock pops 8% as Trump’s $1.5 trillion defense budget call lifts contractors
Previous Story

Leonardo DRS stock pops 8% as Trump’s $1.5 trillion defense budget call lifts contractors

AMD stock slips after-hours as CES AI chip pitch meets “show me” market mood
Next Story

AMD stock slips after-hours as CES AI chip pitch meets “show me” market mood

Go toTop